Share of Cost, Novel Vaccine That Produces Strong Immunity Against Cocaine High Poised To Move Quickly Into Human Trials
Share of Cost, Novel Vaccine That Produces Strong Immunity Against Cocaine High Poised To Move Quickly Into Human Trials: Researchers from The Scripps Research Institute, Weill Cornell Medical College, and Cornell University have produced a long-lasting anti-cocaine immunity in mice by giving them a unique vaccine that combines bits of the common cold virus with a particle that mimics cocaine.